Breaking News

Crucell Receives First Wyeth Biotech Orders

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Crucell has received its first orders for the CMO agreement with NJ-based Wyeth Biotech. The agreement for formulation and filing of a vaccine was finalized at the end of 2005 and will have the first business impact for Crucell in 2007. The vaccine will be supplied from Crucell’s Swiss subsidiary....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters